Kenanoglu, S. Et Al. 2024. Insights into multidrug resistance mechanisms: Exploring distinct miRNAs as prospective therapeutic agents in triple negative breast cancer. Gene Reports , vol.37 .

Kenanoglu, S., AKALIN, H., ASLAN, D., İNANÇ, M., ÖZTÜRK, F., & DÜNDAR, M., (2024). Insights into multidrug resistance mechanisms: Exploring distinct miRNAs as prospective therapeutic agents in triple negative breast cancer. Gene Reports , vol.37.

Kenanoglu, Sercan Et Al. "Insights into multidrug resistance mechanisms: Exploring distinct miRNAs as prospective therapeutic agents in triple negative breast cancer," Gene Reports , vol.37, 2024

Kenanoglu, Sercan Et Al. "Insights into multidrug resistance mechanisms: Exploring distinct miRNAs as prospective therapeutic agents in triple negative breast cancer." Gene Reports , vol.37, 2024

Kenanoglu, S. Et Al. (2024) . "Insights into multidrug resistance mechanisms: Exploring distinct miRNAs as prospective therapeutic agents in triple negative breast cancer." Gene Reports , vol.37.

@article{article, author={Sercan Kenanoglu Et Al. }, title={Insights into multidrug resistance mechanisms: Exploring distinct miRNAs as prospective therapeutic agents in triple negative breast cancer}, journal={Gene Reports}, year=2024}